EUVIMEDEUVIMED entdecken
Crossref

A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory

Mrityunjoy Halder

Bioinformation · 31.10.2026 · 22 (10) · 7069-7076

DOI: 10.6026/973206300227069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Mrityunjoy Halder.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Analytical errors in clinical biochemistry can compromise patient safety and clinical decision-making. Therefore, it is of interest to evaluate a DMAIC-based quality improvement programme for 20 serum chemistry analytes over 11 months. Baseline and endpoint data were compared using CLIA 2025 allowable total error, IQC-derived coefficient of variation, EQA-derived bias and Quality Goal Index analysis. Unacceptable analytes decreased from 11 to 2, while world-class and excellent performers increased from 0 to 4 and 0 to 3, respectively. Thus, data shows the DMAIC-based Six Sigma programme improved analytical performance and supported risk-based quality control planning for sustainable laboratory quality improvement.

Zitieren

APA

Halder, M. (2026). A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory. Bioinformation, 22(10), 7069-7076. https://doi.org/10.6026/973206300227069

Vancouver

Halder M. A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory. Bioinformation. 2026;22(10):7069-7076. doi:10.6026/973206300227069

BibTeX
@article{Halder2026,
  author = {Halder, Mrityunjoy},
  title = {A prospective study of DMAIC-based six sigma implementation for analytical quality improvement in a clinical biochemistry laboratory},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {7069--7076},
  doi = {10.6026/973206300227069}
}
Kostenlos starten →